Answers are grounded in this paper and cite their sources.
Demonstrates the hepatic synthesis and enzymatic conversion of cholest-5-ene-3β,7α,12α-triol in rat liver fractions, clarifying bile acid intermediates.
The synthesis of unlabeled and tritium-labeled cholest-5-ene-3β,7α,12α-triol is described. The formation of cholest-5-ene-3β,7α,12α-triol was shown in incubations of cholesterol and cholest-5-ene-3β,7α-diol with the 20,000 x g supernatant fluid of rat liver homogenates and of cholest-5-ene-3β,7α-diol with the microsomal fraction fortified by addition of reduced nicotinamide adenine dinucleotide phosphate. Cholest-5-ene-3β,7α,12α-triol was found to be converted to 7α,12α-dihydroxycholest-4-en-3-one in the presence of mitochondrial or microsomal fraction fortified with NAD or NADP. The microsomal fraction was more active than the mitochondrial fraction and NAD was several times more active than NADP.
No takes yet. Share an insight, caveat, or question.
Berséus et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: